Regal Assets Analytics

Call Us: (800) 891-1526

M - F 8AM to 4PM ET

SanaCurrents Updates

Harpoon (HARP) Snares Last Minute Share Surge After Positive Phase I Data

By |2020-06-03T10:02:13-04:00May 30th, 2020|Categories: Bill Langbein, Insights, SanaCurrents Updates|Tags: |

Harpoon Therapeutics (NASDAQ:HARP), a biotechnology company developing an antibody platform [...]

Avadel Shares Stable After Nice Run; Cassava Shares Languish on Alzheimer’s Blues

By |2020-05-21T14:33:03-04:00May 18th, 2020|Categories: Bill Langbein, Insights, SanaCurrents Updates|Tags: , |

Avadel Pharmaceuticals plc (NASDAQ:AVDL) recently announced positive phase III trial [...]

Genfit (GNFT) Misses in Late-stage NASH Trial, SanaCurrents Closes Position

By |2020-05-21T14:33:32-04:00May 12th, 2020|Categories: Bill Langbein, SanaCurrents, SanaCurrents Updates|Tags: |

Genfit S.a. (NASDAQ:GNFT) announced after the market closed on May [...]

Acceleron Hits Second Catalyst; Eight More SanaCurrents Catalysts Expected For 2Q 2020

By |2020-04-15T11:07:58-04:00April 15th, 2020|Categories: Bill Langbein, Health Care Equipment & Services, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Updates|Tags: , , , , , , , , , |

Onconova Coverage suspended, Oragenics falls short in Phase II trial.   [...]